PharmaCyte Biotech, Inc. - PMCB
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2026
· Q1 2026
Value (USD)
Total reported value ($000)
$646K
QoQ value delta ($000)
-$94K
(-12.7%)
Implied price effect (QoQ)
+15.98%
Shares
Total shares
848,870
QoQ shares delta
-278,907
(-24.73%)
Total shares held by funds (by quarter)
Market chart (PMCB)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2026)
Top 25 only
Full list
Partial Q2 2026 data: 32 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| CITADEL ADVISORS LLC | 284 | 369,481 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 95 | 124,247 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 43 | 56,778 | 0.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 34 | 44,853 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 29 | 37,987 | 0.0% |
| XTX Topco Ltd | 26 | 34,180 | 0.0% |
| NORTHERN TRUST CORP | 25 | 32,624 | 0.0% |
| JANE STREET GROUP, LLC | 23 | 30,064 | 0.0% |
| Schonfeld Strategic Advisors LLC | 20 | 26,926 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 18 | 23,452 | 0.0% |
| EQUITEC PROPRIETARY MARKETS, LLC | 17 | 22,227 | 0.0% |
| COMMONWEALTH EQUITY SERVICES, LLC | 15 | 20,255 | 0.0% |
| HRT FINANCIAL LP | 11 | 15,451 | 0.0% |
| Tower Research Capital LLC (TRC) | 3 | 4,888 | 0.0% |
| UBS Group AG | 3 | 4,142 | 0.0% |
| HUNTINGTON NATIONAL BANK | 0 | 1 | 0.0% |
| CALDWELL SUTTER CAPITAL, INC. | 0 | 2 | 0.0% |
| HARBOUR INVESTMENTS, INC. | 0 | 3 | 0.0% |
| MORGAN STANLEY | 0 | 2 | 0.0% |
| GROUP ONE TRADING LLC | 0 | 500 | 0.0% |
| Johnson Financial Group, Inc. | 0 | 1 | 0.0% |
| CWM, LLC | 0 | 1 | 0.0% |
| MCF Advisors LLC | 0 | 1 | 0.0% |
| FINANCIAL CONSULATE, INC | 0 | 2 | 0.0% |
| NewEdge Advisors, LLC | 0 | 2 | 0.0% |